10 Best Biotech Penny Stocks to Buy Now
In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities.
Black Diamond Therapeutics Inc. (BDTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vestal Point Capital Ryan Wilder | 5,028,500 | $21,873,975 | +140% | 1.65% |
| 2. | Tang Capital Management Kevin C. Tang | 1,370,209 | $5,960,409 | -15% | 0.42% |
| 3. | 950,000 | $4,132,500 | 0.57% | ||
| 4. | Citadel Investment Group Ken Griffin | 703,704 | $3,061,113 | +15438% | 0% |
| 5. | 700,000 | $3,045,000 | 0.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.34 | 400,000 | 8,517,839 | 2023-10-17 | Filing | ||
| $5.00 | 935,850 | Director | 3,213,828 | 2023-07-05 | Filing | |
| $5.00 | 1,000,000 | Director | 4,448,757 | 2023-07-05 | Filing | |
| $5.00 | 1,000,000 | 8,117,839 | 2023-06-30 | Filing | ||
| $5.49 | 1,740,000 | Large Shareholder | 7,117,839 | 2023-06-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.32 | 221,600 | 3,726,341 | 2024-08-28 | Filing | ||
| $6.70 | 25,000 | 671,423 | 2023-06-27 | Filing | ||
| $28.20 | 351 | Officer | 8,400 | 2021-05-12 | Filing | |
| $27.90 | 2,566 | Officer | 8,751 | 2021-05-12 | Filing | |
| $26.11 | 1,161 | Officer | 11,317 | 2021-05-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,535,839 | $23,985,708 | 0.36% | |
| 2. | 4,448,757 | $12,501,007 | 0.83% | |
| 3. | 1,947,093 | $5,471,331 | 0% | |
| 4. | 1,554,629 | $4,368,507 | 0.03% | |
| 5. | 1,350,047 | $3,793,632 | 0% |
News See All
Hedge Funds Say These 5 Penny Stocks are Poised to Explode
Below you can find the list of 5 penny stocks that are poised to explode according to hedge funds.
10 Healthcare Stocks with Insider Buying
Investors were processing inflation report on August 10 to find clues on the Federal Reserve’s possible moves. CPI’s growth in July was identical to that of June’s.
Hedge Fund and Insider Trading News: Michael Hintze, Bastion Capital, Gersemi Asset Management, Antares Capital, Black Diamond Therapeutics, Inc. (BDTX), and More
Billionaire Michael Hintze’s CQS is exploring options including selling part of its asset-management business, according to people with knowledge of the matter.
Hedge Fund and Insider Trading News: Crispin Odey, Cathie Wood, Said Haidar, Man Group, Black Diamond Therapeutics, Inc. (BDTX), Tri-Continental Corp (TY), and More
Said Haidar, the hedge fund manager known for his stunning gains and losses, is making money once again.
Hedge Fund and Insider Trading News: Bill Ackman, Crispin Odey, King Street Capital Management, Black Diamond Therapeutics, Inc. (BDTX), Nuix Ltd (NXLLF), and More
Brian Higgins has helped guide King Street Capital Management to pounce on some of the most high-profile distressed debt events of the past two decades, from Lehman Brothers Holdings to Revlon Inc.
Is Black Diamond Therapeutics, Inc. (BDTX) Going to Burn These Hedge Funds?
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
Is Black Diamond Therapeutics, Inc. (BDTX) A Good Stock To Buy?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Is BDTX A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Hedge Fund and Insider Trading News: Steve Cohen, Bill Ackman, Laurion Capital, Alden Global Capital, Black Diamond Therapeutics Inc (BDTX), SkyWest, Inc. (SKYW), and More
The potential sale of the New York Mets to Steve Cohen, a billionaire hedge fund manager, is all but dead, Major League Baseball commissioner Rob Manfred said Thursday.
Billionaire Hedge Funds
